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Lipopolyplexes are of widespread interest for gene therapy due to their multifunctionality and high
transfection efficiencies. Here we compared the biological and biophysical properties of a lipopolyplex
formulation with its lipoplex and polyplex equivalents to assess the role of the lipid and peptide components
in the formation and function of the lipopolyplex formulation. We show that peptide efficiently packaged
plasmid DNA forming spherical, highly cationic nanocomplexes that are taken up efficiently by cells.
However, transgene expression was poor, most likely due to endosomal degradation since the polyplex lacks
membrane trafficking properties. In addition the strong peptide-DNA interaction may prevent plasmid
release from the complex and so limit plasmid DNA availability. Lipid/DNA lipoplexes, on the other hand,
produced aggregated masses that showed poorer cellular uptake than the polyplex but contrastingly greater
levels of transgene expression. This may be due to the greater ability of lipoplexes relative to polyplexes to
promote endosomal escape. Lipopolyplex formulations formed spherical, cationic nanocomplexes with
efficient cellular uptake and significantly enhanced transfection efficiency. The lipopolyplexes combined the
optimal features of lipoplexes and polyplexes showing optimal cell uptake, endosomal escape and
availability of plasmid for transcription, thus explaining the synergistic increase in transfection efficiency.
G
ene therapy involves the use of genes for therapeutic purposes and is being evaluated for a number of
diseases. Gene delivery requires a suitable carrier system for which viral vectors are generally more
efficient than their non-viral nanoparticle counterparts. However, the latter are easier to prepare in large
quantities, have a packaging capacity for a wider range of sizes of nucleic acid molecules, ranging from 20
nucleotides to tens of kilobases, and perhaps most importantly, are less immunogenic and so may be more useful
for clinical applications that require repeated gene delivery1. However, whilst significant progress has been made
in developing nanoparticles more efficient, multifunctional formulations are still required to accelerate their
clinical progression for gene therapy.
Felgner et al. in 19872 first reported that cationic liposomes could be formulated with plasmid DNA into self-
assembling complexes that transfected cells while, in the same year,Wu andWu showed that the cationic polymer
poly-L-lysine formed transfection complexes when added to DNA3. A variety of lipoplexes and polyplexes have
since been developed and optimized for gene transfer4,5. Lipopolyplex formulations that combine both liposomes
and polymers have gained popularity in recent years as the mixture of components enables the formation of
nanocomplexes with a wider range of functionalities than either lipoplexes or polyplexes, with higher transfection
efficiencies6–10.
We have previously described LPD nanocomplex formulations for gene delivery comprising a mixture of
cationic liposome (L; e.g., DOTMA/DOPE) and cationic targeting peptide (P) which self-assemble on mixing
withDNA (D) at appropriate ratios11. Derivatives of LPD nanocomplexes have been used for in vivo gene delivery
to lung12,13, vascular tissues14–16 and tumours17,18 achieving efficient gene transfer and displaying therapeutic
effects in tumours18 and vasculature15,16. Importantly, LPD formulations were far more effective transfection
agents than either PD or LD suggesting a synergistic interaction of components.
In the present study the aim was to investigate the basis of the synergistic increase in transfection efficiency of
the LPD formulations compared to its liposome-DNA (LD) and peptide-DNA (PD) counterparts. As a model
lipopolyplex we used an LPD formulation previously optimised for airway gene transfer12. The LPD vector was
formulated with a liposome (L), made up of DHDTMA (1-Propanaminium, N,N,N-trimethyl-2,3-bis (11Z-
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hexadecenyloxy)-iodide) andDOPE lipids, a dual functioning DNA-
condensing and receptor-targeted peptide (P), with the sequence
K16GACSERSMNFCG19 (K16E) and DNA (D) formulated at an
L5P5D weight ratio of 0.755451. We performed detailed structural
and functional analysis of the LPD formulation together with its LD
and PD counterparts. We sought to interrogate the roles of the lipo-
some and peptide in transfection in order to explain the synergy we
and others have observed in transfections with lipopolyplexes. We
aim to use this information to develop more improved nanoparticle
formulations.
Results
In vitro transfections. 16HBE14o- cells were transfected with LPD,
LD and PD formulations with pCI-Luc and luciferase expression
assessed to compare their transfection efficiencies. Transfected
luciferase activity using the LPD formulation was 3.5-fold higher
than that achieved with the LD (451) formulation (Figure 1; p ,
0.001), 15.9-fold greater than the LD (0.7551) formulation (Figure 1;
p , 0.001) and 1030.5-fold higher than with the PD formulation
(Figure 1; p, 0.001). Moreover, LD (451) formulations, but not LD
(0.7551) formulations, gave significantly higher levels of luciferase
activity than PD formulations (Figure 1; p , 0.001). Therefore, the
ternary combination of liposome, peptide andDNAof LPD formula-
tions displayed a synergistic increase in luciferase transgene
expression compared to binary PD and LD formulations (Figure 1).
This synergy in transfection was also observed following HEK-
293T and HT-1080 cell line transfections (Figure S1a and S1b,
respectively). In both cases, transfected luciferase activity using the
LPD formulation was around 3-fold higher than that achieved with
the LD (451) formulation (Figure S1a and S1b; p, 0.001). LD (451)
formulations, but not LD (0.7551) formulations, again gave signifi-
cantly higher levels of luciferase activity than PD formulations
(Figure S1a and S1b; p , 0.001).
Biological barriers to gene transfer. The initial barriers to trans-
fection are cell binding and uptake and differences in efficiencies of
these processes could potentially explain differences in transfection
efficiency of different nanocomplexes. To assess differences in vector
uptake, 16HBE14o- cells were transfected with LPD, PD, and LD
complexes formulated with Cy5-labelled pCI-Luc and plasmid
uptake assessed by flow cytometry. With LD (0.7551) complexes
2.5 6 0.1% of cells showed uptake of plasmid DNA compared to
25.26 0.9%with LD (451) complexes (Figure 2a; p, 0.001). In both
cases LD complexes showed significantly lower levels of plasmid
uptake than PD and LPD complexes, which showed uptake in 50.5
6 5.0%, and 53.4 6 3.1% of cells, respectively (Figure 2a; p, 0.001
for LD vs. LPD/PD), while the small difference in cell uptake between
PD and LPD complexes was not significant. We also assessed the
mean fluorescence intensity (MFI) of Cy5 labelled plasmidwithin the
cells positive for Cy5 (Figure 2b). There was no significant difference
in MFI when comparing the two LD complexes (MFI of 56.7 6 4.8
and 126.86 3.1 for LD (0.7551) and LD (451), respectively) but both
LD complexes showed a significantly lower MFI than LPD (MFI of
10806 33.2) and PD complexes (MFI of 14726 54.2 (Figure 2b; p,
0.001 for LD vs. LPD/PD). Whilst there was no significant difference
between LPD and PD complexes in regards to percentage of trans-
fected cells (Figure 2a), the latter did show significantly higher levels
of Cy5 labelled plasmid within each transfected cell (Figure 2b; p ,
0.001). Confocalmicroscopy images of transfected cells corroborated
these findings and showed that uptake of Cy5 labelled plasmid was
greatest in cells transfected with PD and LPD formulations and
lowest with the LD (0.7551) formulation (Figure S2).
Downstream of cell uptake vectors must escape the endosome
compartment to avoid subsequent degradation in lysosomes. The
DOPE lipid within the DHTDMA:DOPE liposome is known to aid
in this endosomal escape and was crucial in producing efficient
transgene expression with LPD and LD complexes as its replacement
with the non-fusogenic DOPC lipid dramatically decreased trans-
gene expression to PD transfection levels (Figure S3). It was clear
then that vector uptake was the limiting step for LD transfections and
endosomal escape the limiting step for PD transfections.
Having established the limiting steps to transfection with LD and
PD complexes we next investigated whether differences in their bio-
physical properties could explain their different behaviour in cells.
Morphology, size, and charge characterisation. Particle morph-
ology, size and surface charge are all important in determining cell
uptake pathway and efficiency. Transmission electron microscopy
(TEM) and dynamic light scattering (DLS) were used to investigate
the morphology, size and charge of the different complexes. TEM
showed that LPD complexes formed a heterogeneous population of
roughly spherical particles with sizes around 100–200 nm in dia-
meter (Figure 3a and S4a) while PD complexes were also roughly
spherical though particle sizes were smaller than LPD with the
majority falling within the range of 30–60 nm and a few larger
particles with sizes of around 100 nm (Figure 3b and S4b). In
contrast to LPD and PD complexes, LD mixtures at both the
0.7551 and 451 liposome: DNA ratios appeared as aggregated
multi-lamellar structures (Figure 3c and d; Figure S4c and d) with
more rounded particles apparent at the 451 L5D ratio (Figure 3d).
DLS measurements of the four described complexes were consist-
ent with the TEM measurements showing that the PD complexes
were smallest followed by LPD, LD (0.7551) and LD (451) complexes
(Table 1). Zeta potential measurements for LPD, LD (451) and PD
complexes were all cationic but LD (0.7551) complexes showed a
negative zeta potential suggesting that the DNA was not neutralized
or condensed at all (Table 1). The liposome used in this study had a
smaller hydrodynamic size than both LD (451) and LD (0.7551)
complexes as well as a higher surface charge. A mixture of liposome
and peptide (LP) showed a similar hydrodynamic size to liposome
alone (Table 1) suggesting no interaction between liposome and
peptide.
DNA condensation and packaging. Differences observed in the
morphology, size and charge of the LD, PD and LPD formulations
indicates differences in DNA condensation and packaging. DNA
condensation was assessed using gel retardation and fluorescence
quenching assays while DNA release from each nanocomplex was
Figure 1 | Luciferase activity, measured in relative light units (RLU) per
mg of protein following transfection of 16HBE14o- cells with pCI-Luc
complexed into LPD, LD (0.7551), LD (451) and PD nanocomplexes.
Values aremean6 SEM; n5 5;NS, not significant, ***P, 0.001; one-way
ANOVA with Bonferroni post-test analysis used to assess significance.
www.nature.com/scientificreports
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assessed by incubation with the highly anionic heparan sulphate to
promote dissociation.
With LD (0.7551) complexes a significant amount of plasmid was
not retarded indicating poor plasmid condensation while LD (451)
complexes completely retarded plasmid DNA in the wells
(Figure 4a). LPD and PD complexes also showed retarded plasmid
mobility but with greater ethidium bromide exclusion than the LD
(451) complexes as suggested by the fainter signal in the wells com-
pared to the LD (451) complexes (Figure 4a). The observed differ-
ences in plasmid DNA condensation were further supported by
quenching experiments using the PicoGreen assay (Figure 4b).
When normalised to free plasmid 30.5 6 1.2% of PicoGreen labelled
plasmid was quenched in LD (451) complexes which contrasted with
the 73.5 6 0.1% and 75.9 6 0.04% quenching of fluorescence seen
when using LPD and PD complexes respectively. LD (0.7551) com-
plexes did not show any detectable quenching of PicoGreen labelled
plasmid. Taken together the data indicated that LPD and PD com-
plexes packaged plasmid DNA more efficiently than LD complexes.
Agarose gel analysis showed that heparan sulphate treatment lib-
erated plasmid DNA from LPD and PD samples readily but less well
from LD (451) complexes. The organisation and packaging of plas-
mid DNA is thus similar in LPD and PD complexes and dissimilar in
LPD and LD (451) complexes. PicoGreen release studies showed that
LPD and PD complexes were more stable than LD complexes in
response to increasing concentrations of heparan sulphate. This
study also revealed that PD complexes were more stable than LPD
as less DNA was released from PDs by heparan sulphate incubation.
Initial differences in levels of PicoGreen quenching of plasmid DNA
were only 2.4% (Figure 4b) but this increased to 5.7% in 5 U/mL
heparan sulphate (22.2% of fluorescence quenched for LPD and
27.9% for PD, p , 0.001; Figure 4b). Release of plasmid DNA may
therefore bemore efficient with the LPD complexes than with the PD
complexes.
Liposome, peptide, DNA interactions in forming LPD particles.
Having established differences in the biophysical properties of LPD,
LD and PD complexes we sought to investigate the roles played by
the liposome, peptide and DNA in forming the different complexes.
This was completed by systematically probing the circular and linear
dichroism spectra of the different components individually, in binary
mixtures and finally in the ternary LPD complex to gain an
understanding of how the different components of the LPD vector
interact with one another.
Circular (Figure 5a) and linear (Figure 5b) dichroism spectra for
plasmid DNA alone were indicative of relaxed B-formDNAwhich is
typical for DNA in aqueous solution20. The circular dichroism spec-
trum of the peptide had the characteristics of an unfolded conforma-
tion with a minimum at ,200 nm and a maximum at ,216 nm
(Figure 5a)21 while, as expected, the linear dichroism spectrum
revealed no appreciable signals for the peptide (Figure 5b).
Neither circular dichroism nor linear dichroism signals were
obtained for liposome samples due to the absence of chromophores
absorbing in the UV region (Figure 5a and b). Linear dichroism
spectra for liposomes in the presence of b-DPH HPC, a molecular
probe which inserts into lipid bilayers to reveal liposome orientation,
had a minimum at ,320 nm (Figure 5c) suggesting that the lipo-
somes were aligned in the shear flow as expected22. b-DPHHPC had
no effect on the linear dichroism spectrum of peptide or DNA
(Figure 5c) suggesting that neither interacted with the probe.
There was no evidence for peptide-lipid interactions in binary LP
mixtures (liposome: peptide ratio of 155.3) from either spectrum
(Figure 6a and b). The circular dichroism spectra for PD complexes
(Figure 6a) did not reveal notable changes in peptide or DNA struc-
tures and appeared to be averages of circular dichroism spectra of the
individual components. However, the flattening of the linear dichro-
ism spectrum for DNA (Figure 6c) in PD complexes indicated non-
specific interactions, such as electrostatic complexation, rather than
co-folding23. LD (0.7551) complexes also showed no apparent
changes in DNA structure (Figure 6d and e) and highlighted the
relatively poor DNA condensation in LD complexes (Figure 6e).
Addition of the b-DPH HPC probe into different binary mixtures
of all three individual components gave rise to the same characteristic
band at,320 nmwith increases in intensity for LD(0.7551), LP#
PD, whereas LPD showed appreciably stronger signals (Figure 7a).
The observed increases suggest that the probe integrates more
strongly into nanocomplexes with a more pronounced internal
order. This is important for two reasons. Firstly, because the probe
does not interact with individual peptide and DNA components,
but does with liposomes and complexes, it is the supramolecular
arrangements of individual components that support probe-complex
interactions. Secondly, because the binding of the probe is predomi-
nantly driven by the hydrophobic effect inter-component interac-
Figure 2 | Flow cytometry analysis showing (a) the percentage of Cy5 positive cells and (b) themean fluorescent intensity of Cy5 positive cells following
a 6 hour incubation of 16HBE14o- cells with Cy5 labelled pCI-Luc complexed into LD (0.7551), LD (451), PD and LPD complexes. Values are
mean 6 SEM; n 5 6; NS, not significant; ***P , 0.001; one-way ANOVA with Bonferroni post-test analysis used to assess significance.
www.nature.com/scientificreports
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tions in the complexes set up exposed hydrophobic regions (DNA
bases, hydrophobic amino-acid side chains, lipid aliphatic chains)
that are sufficiently extensive to support continuous probe binding.
The hydrophobic nature of probe-complex interactions is further
confirmed by dynamic light scattering (Table 1), which showed no
correlations between the sizes and charges of the complexes. In this
notation, the linear dichroism data suggests that PD complexes pro-
vide stronger hydrophobic interactions than LD. Signals for LPD,
which are approximately two-fold stronger than those for LD or PD,
are likely to comprise contributions from both types of interactions,
LD and PD. Essentially the same circular dichroism spectra for LPD
and PD complexes (Fig. 7b) imply that hydrophobic exposure is not a
result of folding-mediated assembly and does not necessarily lead to
more stable formulations.
Discussion
Lipopolyplex vectors comprising formulations of liposomes, cationic
targeting peptides and DNA (LPD) show significantly higher trans-
fection efficiencies than their liposome-DNA (LD) lipoplex or pep-
tide-DNA (PD) polyplex equivalents, and this has also been observed
with other lipopolyplex formulations6–9,11. The enhancement of
transfection efficiency of LPD formulations is more than an additive
effect of LD and PD transfections, suggesting a co-operative effect
between the liposome and peptide components in the enhancement
of transfection. To better understand the enhanced transfection effi-
ciency properties of LPD vectors we undertook a systematic analysis
of the biological and biophysical properties of binary LD and PD
complexes and the ternary LPD complex and investigated the roles of
the liposome, peptide and DNA components in the formation and
function of the LPD vector.
In the transfection process several key steps must take place to
allow for efficient gene expression including, i) the formation of
stable particles that can protect plasmid DNA from degradation, ii)
attachment of vector to cells, iii) uptake of the vector into cells, iv)
Figure 3 | Transmission electron micrographs of (a) LPD, (b) PD, (c) LD (0.7551) and (d) LD (451) complexes. Scale bars are 500 nm.
Table 1 | Hydrodynamic size and zeta potential of complexes
Nanocomplex Size (nm) Zeta potential (mV)
LPD 58.0 6 0.2 167.2 6 2.1
LD (0.7551) 116.1 6 1.1 220.8 6 0.2
LD (451) 280.3 6 1.0 132.5 6 0.5
PD 44.6 6 0.1 131.0 6 0.6
Liposome 82.1 6 1.1 160.1 6 0.9
LP 86.6 6 0.5 174.9 6 1.7
www.nature.com/scientificreports
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endosomal escape, v) nuclear entry and vi) release of plasmid DNA
from the nanocomplex for transcription.
Our data show that the formation of small discrete cationic part-
icles is a consequence of peptide/DNA interactions in the LPD com-
plexes.We show that cationic peptidesmore efficiently condense and
package DNA than cationic liposomes, a phenomenon seen in pre-
vious studies and most likely due to the higher charge density of the
peptide molecules24. In addition, peptide containing complexes were
more stable to heparan sulphate challenge indicating greater protec-
tion to the packaged DNA.
Attachment of vector to cells is determined primarily by the sur-
face charge of the vector with cationic complexes being attracted to
the anionic cell surface and differences could affect cell binding and
vector internalisation25. In contrast to the peptide component the
amount of liposome used in the LPD complexes was not sufficient
to neutralise plasmid DNA highlighting that the formation of cat-
ionic particles is also a function of the peptide component.
Cellular uptake follows vector binding and we show that PD and
LPDnanocomplexes were internalised to similar degrees whilst, rela-
tive to LPD and PD complexes, LD (451) complexes showed poor
cellular uptake. These differences could be explained by the fact that
PD and LPD formulations formed small, spherical and discrete part-
icles in contrast to LD formulations which generally formed large
aggregates26. Differences in cellular uptake when comparing LPD
Figure 4 | (a) Gel retardation assay showing 250 ng naked pCI-Luc, LD (0.7551), LD (451), PD, and LPD complexes incubated for 1 hour at room
temperature in the presence or absence of 20 U/mL heparan sulphate. (b) PicoGreen fluorescence quenching was used to assess the stability of the
different complexes to heparan sulphate challenge as well as assess the quenching capabilities of the different complexes in the absence of heparan
sulphate. The level of PicoGreen fluorescence was measured in relative fluorescence units (RFU) with naked PicoGreen labelled pCI-Luc plasmid set as
100% RFU. Values are mean 6 SEM; n 5 6.
www.nature.com/scientificreports
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and LD (451) complexes correlated well with differences in luciferase
gene expression suggesting that cellular uptake was the primary bar-
rier to LD transfections.
LPD and PD complexes formed nanoparticles with similar bio-
physical characteristics and displayed good cellular uptake so we
hypothesised that the differences in their transfection efficiencies
lay in differences in their ability to overcome intracellular barriers
to transfection. Endosomal escape and nuclear uptake are down-
stream of vector uptake and potential barriers hindering efficient
transgene expression following PD transfections. Since these studies
were performed in dividing cell cultures the nuclear envelope is less
of a barrier so we proposed that the greater transfection efficiency of
LPD was due to improved endosomal escape mediated by the fuso-
genic DOPE lipid within the LPD nanocomplex. This hypothesis was
supported by the finding that replacement of DOPE in the LPD
nanocomplex with the non-fusogenic DOPC lipid eradicated differ-
ences in transfection efficiency of LPD and PD complexes.
A further potential limiting factor in transfection efficiency is the
dissociation potential of DNA from nanocomplexes within the cell
which is necessary to enable access to the transcriptional
machinery27–29. Our data show that plasmid DNA in PD complexes
are more tightly packaged than in LPD complexes while DNA was
more easily released from LPD complexes than from PD complexes.
Linear and circular dichroism showed a weaker peptide-DNA inter-
action in LPD complexes suggesting that the cationic liposome inter-
feres with the peptide-DNA interaction in LPD complexes either
through steric effects or possibly by competing for interaction with
anionic residues on the phosphate backbone of the plasmid DNA.
This interference with peptide-DNA interactions in LPD nanocom-
plexes would lead to reduced water exclusion, charge neutralisation
and compaction of the DNA that manifests as slightly larger particles
as was observed. The weakening of the peptide-DNA interaction
would alsomake it easier for anionic species within the cells to induce
dissociation of the nanocomplex27–29 so enabling greater access of
DNA to the transcriptional machinery potentially contributing to
enhanced transgene expression.
In conclusion, using a lipopolyplex optimised for airway gene
delivery we have shown that lipopolyplexes show a synergistic
enhancement in the efficiency of transgene expression when com-
pared to their relevant polyplexes and lipoplexes. Cellular uptake of
the nanocomplexes was the primary barrier to gene transfer with the
lipoplex whilst inefficient intracellular trafficking hampered trans-
gene expression by the polyplex. Having both peptide and liposome
components in the lipopolyplex produced a cationic nanocomplex
that showed efficient cellular uptake, a function of the peptide com-
ponent, as well as efficient endosomal escape, a function of the lipo-
some component. This increased functionality afforded by having
both the liposome and peptide in lipopolyplexes can help explain the
synergy observed in transgene expression when comparing lipo-
plexes, polyplexes and lipopolyplexes.
Methods
Materials. Plasmids pCI-Luc and pEFGP-N1 were prepared as previously
described12. Plasmid pCI-Luc comprises the luciferase reporter gene sub-cloned into
the eukaryotic expression vector pCI (Promega, Southampton, UK) with
Figure 5 | (a) Circular dichroism and (b) linear dichroism spectra of individual components of the LPD complex inwater. (c) Linear dichroism spectra of
the individual components of the LPD complex following the addition of b-DPH HPC.
www.nature.com/scientificreports
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transcription driven by the cytomegalovirus immediate/early promoter-enhancer13.
The plasmid pEGFP-N1 was purchased from Clontech (Saint-Germain-en-Laye,
France). Peptide K16GACSERSMNFCG19 was synthesised by Zinsser Analytic
(Maidenhead, UK), and dissolved in endotoxin-free water (Sigma-Aldrich, Dorset,
UK) to 10 mg/mL. Liposomes consisted of 1-Propanaminium, N,N,N-trimethyl-2,3-
bis(11Z-hexadecenyloxy)-iodide (DHDTMA iodide; Avanti Polar Lipids; Alabama,
USA) with either dioleoylphosphatidylethanolamine (DOPE; Avanti Polar Lipids;
Alabama, USA) or dioleoylphosphatidylcholine (DOPC; Avanti Polar Lipids;
Alabama, USA) formulated at a 151 weight ratio, dissolved in sterile water to give a
2 mg/mL liposome suspension.
Cell culture. 16HBE14o- cells (human bronchial epithelia origin; kind gift from
Dieter Gruenert, San Francisco30) were cultured in complete media consisting of
Eagle’s Minimal Essential Medium (MEM; Sigma-Aldrich, Dorset, UK)
supplementedwith 10% (v/v) foetal bovine serum, 2 mmol/l L-glutamine.HEK-293T
andHT-1080 cells were cultured inDulbecco’sModified EagleMedium (DMEM; Life
Figure 6 | (a) Circular dichroism spectra of liposome-peptide (LP) formulation and PD complexes. (b) Linear dichroism spectra of LP formulation
overlaid with linear dichroism spectra of individual liposome (L) and peptide (P). (c) Linear dichroism spectra of PD complexes overlaid with linear
dichroism spectra of individual plasmid DNA (D) and peptide (P). (d) Circular dichroism spectra of LD (0.7551) complexes overlaid with circular
dichroism spectra of individual liposome (L) and plasmid DNA (D). (e)Linear dichroism spectra of LD (0.7551) complexes overlaid with linear
dichroism spectra of individual L and D.
www.nature.com/scientificreports
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Technologies, UK) supplemented with 10% (v/v) foetal bovine serum. Cells were
incubated in humidified 5% CO2 at 37uC.
In vitro transfections. Cells were seeded in 96-well plates at a density of 20,000 cells
per well and incubated in humidified 5% CO2 at 37uC for 24 hours. For luciferase
assay experiments cells were seeded in black plates with clear bottoms (Fisher
Scientific UK, Leicestershire, UK). All complexes were prepared in OptiMEM
(Invitrogen, Paisley, UK). LPD complexes were prepared at a 0.755451weight ratio of
liposome: peptide: plasmid DNA12; PD complexes were formulated at a 451 peptide:
plasmid DNA weight ratio and LD complexes were prepared either at a 0.7551 (LD
(0.7551)) or 451 (LD (451)) weight ratio of liposome: plasmid DNA. Complexes were
formulated to a plasmid DNA concentration of 10 mg/mL and incubated at room
temperature for 30 minutes to allow for complex self-assembly. LPD formulations
were prepared by first mixing the cationic liposome and peptide solutions and then
adding the plasmid DNA solution. Cells were transfected in replicates with 25 mL of
the formulated complex solution (250 ng plasmid DNA) added to 175 mL of
complete media per well. Luciferase and protein assays were performed 24 hours
following transfection.
Luciferase assay. Cells were washed with 13 PBS 24 hours following transfection
and lysed with 20 mL Reporter Lysis Buffer (Promega, Southampton, UK) for
20 minutes at 4uC then 280uC for at least 30 minutes followed by thawing at room
temperature. Luciferase activity was assessed using the Luciferase Assay System
(Promega, Southampton, UK) on a FLUOstar Optima plate reader (BMG Labtech,
Aylesbury, UK). The results were standardised for protein content using the Bradford
protein assay (Bio-Rad, Hertfordshire, UK) and expressed as relative luminescence
units (RLU/mg of protein).
Cell uptake of Cy5 labelled plasmid. pCI-Luc plasmid was labelled with Cy5 using
the Universal Linkage System Nucleic Acid Labelling Kit (Kreatech Diagnostics,
Amsterdam, TheNetherlands). Labelled plasmidwasmixed 154with unlabelled pCI-
Luc plasmid and complexed into LD (0.7551), LD (451), PD (451) and LPD and used
for transfection of 16HBE14o- cells and the cells were then incubated with the
complexes in humidified 5% CO2 at 37uC for 6 hours and then processed for flow
cytometry and laser scanning confocal microscopy.
Flow cytometry.Adherent cells in 96 well plates were detached using 50 mL Trypsin-
EDTA (Sigma-Aldrich, Dorset, UK) and re-suspended with 150 mL DPBS (Sigma-
Aldrich, Dorset, UK). Cells were then acquired with a BD FACSArray flow cytometer
(BD Biosciences Oxford, UK) and analysis was performed with FlowJo software v.
8.8.3 (Tree Star Inc., Olten, Switzerland).
Laser scanning confocal microscopy. Transfected cells were fixed with 4%
paraformaldehyde, and the nucleus and F-actin were stained with 4’,6-diamidino-2-
phenylindole (DAPI) and Alexa Fluor 488 Phalloidin (Life Technologies, Paisley,
UK) respectively. Images were obtained using a Zeiss LSM 710 Confocal (Carl Zeiss
Ltd., Cambridge, UK).
Electronmicroscopy. LD (0.7551), LD (451), PD, and LPD complexes were prepared
as above for transfections except in water rather than OptiMEM. A 5 mL aliquot was
applied onto a 300-mesh copper grid coated with a Formvar/carbon support film
(Agar Scientific, Essex, UK) then, after a few seconds, dried by blotting with filter
paper. The sample was then negatively stained with 1% uranyl acetate for a few
seconds, before blotting with filter paper and air dried. Imaging was carried out with a
Philips CM120 BioTwin Transmission Electron Microscope and operated at an
accelerating voltage of 120 kV.
Hydrodynamic size and zeta potential measurements.Aqueous preparations of LD
(0.7551), LD (451), PD, and LPD complexes prepared as for electron microscopy
above were diluted to a final volume of 1 mL in distilled water at a concentration of 5
mg/mL plasmid DNA and then analysed for hydrodynamic size and surface charge (f
potential) using a Malvern Nano ZS (Malvern, Worcestershire, UK). Aqueous
preparations of liposome alone and a liposome-peptide mixture (LP; liposome:
peptide ratio of 155.3) were also diluted in a final volume of 1 mL in distilled water at
a concentration of 5 mg/mL of liposome before being analysed as above. The data was
collected and processed by the manufacturer’s software, DTS version 5.03.
Gel retardation assay. LD (0.7551), LD (451), PD, and LPD complexes were
prepared in water, then some formulations were treated with 10 U/mL heparan
sulphate (Sigma-Aldrich, Dorset, UK) for 1 hour at room temperature. Samples
containing 250 ng of plasmid DNA complexed into particles (or plasmid DNA alone
as a control) were loaded onto a 1% agarose gel, made in Tris-acetate-EDTA (TAE)
buffer and stained with 1 mg/mL ethidium bromide, and electrophoresed at a voltage
of 100 V for 1 hour with TAE as the running buffer.
PicoGreen fluorescence quenching. 250 ng of plasmid DNA was mixed with
PicoGreen reagent (15150; Invitrogen, Paisley UK) in TE buffer and incubated for
5 minutes at room temperature. The stained plasmid DNA was then formulated into
LD (0.7551), LD (451), PD, and LPD complexes as above but using TE buffer.
Varying concentrations of heparan sulphate (0–10 U/mL; Sigma-Aldrich, Dorset,
UK) diluted in TE buffer were then mixed with the complexes and incubated for a
further hour at room temperature then fluorescence was analysed at excitation and
emission wavelengths of 485 nm and 520 nm, respectively using the FLUOstar
Optima plate reader (BMGLabtech, Aylesbury, UK). Values were collected as relative
fluorescence units (RFU) and these were then normalised to naked plasmidDNA that
was stained with PicoGreen and treated with the varying concentrations of heparan
sulphate.
Circular dichroism. Circular dichroism measurements were performed with
aqueous preparations of LD (0.7551), LD (451), PD, and LPD complexes, as well as
liposome, peptide and plasmid DNA components at concentrations consistent with
those for the LPD complex. The individual components were used as controls to
determine their native structures. All spectra were obtained in a JASCO J-810
spectropolarimeter using a 0.1 cm rectangular quartz cuvette cell, at a scan rate of
50 nm/min, data pitch of 1 nm, response time of 1 s and bandwidth of 1 nm.
Linear dichroism. LD (0.7551), LD (451), PD, and LPD complexes were formulated
as above for circular dichroism. Liposome, peptide and plasmid DNA were used as
controls to probe the orientation of the individual components under laminar flow. A
1 mg/mL solution of b-DPH-HPC, (2-(3-(diphenylhexatrienyl)propanpyl)-1-
hexadecanoyl-sn-glycero-3-phosphocholine; Invitrogen, Paisley, UK), in ethanol
was, where stated, added to different formulations at a final concentration of 12.5 mg/
mL. The probe incorporates into the liposome bilayer and orients with the liposome
thus enabling the determination of the relative orientation of the liposome from the
linear dichroism signal of b-DPH-HPC22.
Solution-phase flow linear dichroism spectra were obtained on the same Jasco-810
spectropolarimeter as for circular dichroism, which was adapted by substituting the
photo elastic modulator (PEM) 1/2 wave plate instead of a 1/4 wave plate22,31. Linear
dichroism spectra were acquired in a quartz Couette flow cell of ,0.5 mm annular
gap (Kromatec Ltd, UK). Molecular alignment was achieved through the constant
flow of the sample solution between two coaxial cylinders – a stationary quartz rod
and a rotating cylindrical capillary. The laminar flow for the efficient alignment was
obtained by maintaining the rotation speed at ,3000 rpm and a non-rotating
Figure 7 | (a) Linear dichroism spectra of LP formulation and LD (0.7551), PD, and LPD complexes. (b) Circular dichroism spectra LPD and PD
complexes and LP formulation.
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baseline spectrumwas subtracted22,32,33. The linear dichroism spectra were the average
of four accumulations in continuousmode using a scan rate of 50 nm/min, data pitch
of 1 nm, response time of 1 s and bandwidth of 2 nm.
Statistical analysis. Data are mean values 6 standard error of the mean (SEM). A
one-way ANOVA with Bonferroni post-hoc test was used to assess statistical
significance. Significance levels were set at p , 0.05. * 5 p , 0.05; ** 5p , 0.01;
*** 5p , 0.001; NS 5 not significant.
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